6Endocrine approaches to male fertility control

Akhtar, 1982, Pituitary and testicular functions in sexually mature rhesus monkeys under high-dose LHRH-agonist treatment, Acta Endocrinologica, 101, 113, 10.1530/acta.0.1010113 Akhtar, 1983, Reversible induction of azoospermia in rhesus monkeys by constant infusion of a GnRH agonist using osmotic minipumps, Journal of Clinical Endocrinology and Metabolism, 56, 534, 10.1210/jcem-56-3-534 Akhtar, 1983, Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male monkeys, International Journal of Andrology, 6, 461, 10.1111/j.1365-2605.1983.tb00560.x Akhtar, 1985, Acute and chronic effects of a gonadotrophin releasing hormone agonist on pituitary and testicular function in monkeys, Journal of Endocrinology, 104, 345, 10.1677/joe.0.1040345 Barfield, 1979, Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters, Contraception, 20, 121, 10.1016/0010-7824(79)90084-2 Belchetz, 1978, Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone, Science, 202, 631, 10.1126/science.100883 Belkien, 1985, Pharmacokinetics of 19-nortestosterone esters in normal men, Journal of Steroid Biochemistry, 22, 623, 10.1016/0022-4731(85)90215-8 Bergquist, 1979, Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue, Acta Endocrinologica, 91, 601, 10.1530/acta.0.0910601 Bhasin, 1986, Mechanisms of gonadotropin-releasing hormone agonist action in the human male, Endocrine Reviews, 7, 106, 10.1210/edrv-7-1-106 Bhasin, 1985, Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonistand androgen, Journal of Clinical Endocrinology and Metabolism, 60, 998, 10.1210/jcem-60-5-998 Bhasin, 1985, Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittentadministration?, Fertility and Sterility, 44, 96, 10.1016/S0015-0282(16)48684-X Clayton, 1982, Absence of gonadotropin-releasing hormone receptors in human gonadal tissue, Nature, 299, 56, 10.1038/299056a0 Delanoe, 1984, Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception, Lancet, i, 276, 10.1016/S0140-6736(84)90144-2 Doelle, 1983, Combined treatment with an LHRH agonist and testosterone in man: reversible oligospermia without impotence, Journal of Andrology, 4, 298, 10.1002/j.1939-4640.1983.tb02373.x Evans, 1984, Gonadotropin and steroid secretory pattern during chronic treatment with a luteinizing hormone releasing hormone analog in men, Journal of Clinical Endocrinology and Metabolism, 58, 862, 10.1210/jcem-58-5-862 Evans, 1984, A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man, Journal of Clinical Investigation, 73, 262, 10.1172/JCI111200 Fogh, 1979, The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men, Acta Endocrinologica, 91, 545, 10.1530/acta.0.0910545 Happ, 1978, Gonadotropin secretion in eugonadotropic human males and postmenopausal females under long-term application of a potent analog ofgonadotropin-releasing hormone, Fertility and Sterility, 30, 674, 10.1016/S0015-0282(16)43695-2 Heber, 1984, The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man, Journal of Clinical Endocrinology and Metabolism, 58, 1084, 10.1210/jcem-58-6-1084 Heller, 1950, Improvement in spermatogenesis following depression of human testes with testosterone, Fertility and Sterility, 1, 415, 10.1016/S0015-0282(16)30302-8 Karten, 1986, Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspectives, Endocrine Reviews, 7, 44, 10.1210/edrv-7-1-44 Kirkpatrick, 1982, Reversible chemical fertility control in feral horses, Equine Veterinary Sciences, 22, 114, 10.1016/S0737-0806(82)80003-8 Knuth, 1985, Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation, Fertility and Sterility, 44, 814, 10.1016/S0015-0282(16)49043-6 Labrie, 1985, Complete androgen blockade for the treatment of prostate cancer, 193 Labrie, 1986, Treatment of prostate cancer with gonadotropin releasing hormone agonist, Endocrine Reviews, 7, 67, 10.1210/edrv-7-1-67 Leonard, 1978, Contraceptive development studies for males: oral and parenteral steroid hormone administration, 223 Linde, 1981, Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men, New England Journal of Medicine, 305, 663, 10.1056/NEJM198109173051203 Mainwaring, 1977 Mann, 1984, Influence of continuous gonadotropin-releasing hormone (GnRH) agonist treatment on luteinizing hormone and testosterone secretion, the response to GnRH, and the testicular response to human chorionic gonadotropin in male rhesus monkeys, Journal of Clinical Endocrinology and Metabolism, 58, 262, 10.1210/jcem-58-2-262 Marshall, 1983, Stimulation of spermatogenesis in stalk-sectioned rhesus monkeys by testosterone alone, Journal of Clinical Endocrinology and Metabolism, 57, 152, 10.1210/jcem-57-1-152 Marshall, 1984, Testosterone can initiate spermatogenesis in an immature nonhuman primate (Macaca fascicularis), Endocrinology, 114, 2228, 10.1210/endo-114-6-2228 Matsuo, 1971, Structure of the porcine LH- and FSH-releasing hormone I. The proposed amino acid sequence, Biochemical and Biophysical Research Communications, 43, 1334, 10.1016/S0006-291X(71)80019-0 Mauss, 1974, Investigations on the use of testosterone oenanthate as male contraceptive agent, Contraception, 10, 281, 10.1016/0010-7824(74)90006-7 Mauss, 1978, Demonstration of the reversibility of spermatozoa suppression by testosterone oenanthate, Andrologia, 10, 149, 10.1111/j.1439-0272.1978.tb01331.x Meyer, 1985, Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate, Fertility and Sterility, 43, 102, 10.1016/S0015-0282(16)48326-3 Michel, 1985, Failure of high-dose sustained release luteinizing-releasing hormone agonist (buserelin) plus oral testosterone to suppress mate fertility, Clinical Endocrinology, 23, 663, 10.1111/j.1365-2265.1985.tb01127.x Moltz, 1980, Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men, Contraception, 21, 393, 10.1016/S0010-7824(80)80017-5 Nieschlag, 1978, Clinical trial with testosterone undecanoate for male fertility control, Contraception, 18, 607, 10.1016/0010-7824(78)90045-8 1978 Paulsen, 1978, Male contraceptive development: re-examination of testosterone enanthate as an effective single entity agent, 17 Rabin, 1984, Heterogeneity of sperm density profiles following 20-week therapy with high dose LHRH analog plus testosterone, Journal of Andrology, 5, 176, 10.1002/j.1939-4640.1984.tb02390.x Rao, 1972, Reversible antifertility action of testosterone propionate in human males, Contraception, 5, 295, 10.1016/0010-7824(72)90068-6 Resko, 1982, Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in themale rhesus monkey, Biology of Reproduction, 26, 378, 10.1095/biolreprod26.3.378 Saartok, 1984, Relative binding affinity of anabolicandrogenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate,as well as to sex hormone-binding globulin, Endocrinology, 114, 2100, 10.1210/endo-114-6-2100 Sanchez, 1979, Inhibition of spermatogenesis with monthly injections of medroxyprogesterone acetate and low dose testosterone enanthate, International Journal of Andrology, 2, 136, 10.1111/j.1365-2605.1979.tb00047.x Schaison, 1984, Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH210 GnRH ethylamide (buserelin) on testicular steroidogenesis in men, Journal of Clinical Endocrinology and Metabolism, 58, 885, 10.1210/jcem-58-5-885 Schearer, 1978, The use of progestins and androgens as a male contraceptive, International Journal of Andrology, 680, 10.1111/j.1365-2605.1978.tb00517.x Schulte-Beerbühl, 1980, Comparison of testosterone, DHT, LH and FSH in serum after injection o£ testosterone enanthate or testosterone cypionate, Fertility and Sterility, 33, 201, 10.1016/S0015-0282(16)44543-7 Schürmeyer, 1984, Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and saliva testosterone in normal men, International Journal of Andrology, 7, 181, 10.1111/j.1365-2605.1984.tb00775.x Schürmeyer, 1983, Saliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal men, Acta Endocrinologica, 102, 456, 10.1530/acta.0.1020456 Schürmeyer, 1984, Reversible azoospermia induced by the anabolic steroid 19-nortestosterone., Lancet, i, 417, 10.1016/S0140-6736(84)91752-5 Schürmeyer, 1984, Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion, Journal of Clinical Endocrinology and Metabolism, 59, 19, 10.1210/jcem-59-1-19 Soufir, 1983, Reversible inhibition of sperm production and gonadotropin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment, Acta Endocrinologica, 102, 625, 10.1530/acta.0.1020625 Srinath, 1983, Active immunization with follicle stimulating hormone for fertility control: a 4½-year study in male rhesus monkeys, Fertility and Sterility, 40, 110, 10.1016/S0015-0282(16)47187-6 Sundaram, 1982, Inhibition of pituitary testicular function with D-Trp6-LHRH in rhesus monkeys, Endocrinology, 110, 1308, 10.1210/endo-110-4-1308 Sundaram, 1984, Effect of an LHRH agonist on pituitary and testicular function in rhesus monkeys, Journal of Reproduction and Fertility, 72, 365, 10.1530/jrf.0.0720365 Swerdloff, 1985, Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment, Journal of Steroid Biochemistry, 23, 855, 10.1016/S0022-4731(85)80027-3 Toth, 1982, Journal of Steroid Biochemistry, 17, 653, 10.1016/0022-4731(82)90567-2 Vickery, 1980, Effects of continuous treatment of male baboons with superagonists of luteinizing-releasing hormone, International Journal of Fertility, 25, 179 Wang, 1980, Use of low-dosage oral cyproterone acetate as a male contraceptive, Contraception, 21, 245, 10.1016/0010-7824(80)90005-0 Weinbauer, 1984, Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis), Fertility and Sterility, 42, 906, 10.1016/S0015-0282(16)48264-6 Weinbauer GF, Marshall GR & Nieschlag E (1986) New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months. Acta Endocrinologica (in press). Wickings, 1981, Effects of chronic, high-dose LHRH-agonist treatment on pituitary and testicular functions in rhesus monkeys, Journal of Andrology, 2, 72, 10.1002/j.1939-4640.1981.tb00598.x Wickings, 1983, Immunological approach to male fertility control, 249 World Health Organization (WHO), 1983, Special Programme of Research Development and Research Training in Human Reproduction